Tate & Lyle releases transcript of year-end March 31, 2026 results call

  • Tate & Lyle’s results presentation for the year ended March 31, 2026 featured CEO Nick Hampton and CFO Sarah Kuijlaars, with analysts from Bank of America, Redburn Atlantic, Deutsche Numis, Goodbody, Kepler Cheuvreux, Investec, and BNP Paribas Exane taking part.
  • Management highlighted the CP Kelco combination as completing the group’s shift to a specialty Food and Beverage Solutions model, with pro forma revenue down 3% and pro forma EBITDA up 5%, implying a 21% EBITDA margin.
  • Guidance for the year ending March 31, 2026 pointed to revenue growth at or slightly below the bottom of the 4%-6% medium-term range, with EBITDA growth set to outpace revenue on productivity, cost synergies, and continued investment.
  • Tariff exposure was described as mainly US-China, with China representing about 2% of revenue; management flagged manageable direct impacts and limited signs of customer pre-buying, with pass-through handled in a “disciplined and sensitive” way.
  • Kuijlaars cited $50 million of productivity savings, confidence in delivering more than $25 million of cost synergies in the coming year versus a $50 million target by the end of the 2027 financial year, net debt/EBITDA at 2.2x, and a final dividend of GBP 0.134 per share.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tate & Lyle plc published the original content used to generate this news brief on May 21, 2026, and is solely responsible for the information contained therein.